Bone grafting and substitutes in spine surgery

Journal of Neurosurgical Sciences

Volumn 56, Issue 2, 2012, Pages 87-95

  Cabraja, M ^a   Kroppenstedt, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bone morphogenetic proteins; Bone transplantation; Spine

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; VASCULOTROPIN;

BONE ALLOGRAFT; BONE CONDUCTION; BONE DEVELOPMENT; BONE PROSTHESIS; BONE TRANSPLANTATION; DONOR; ECONOMIC ASPECT; FIXATION DEVICE; HUMAN; ILIAC CREST; MEDICAL LITERATURE; MORBIDITY; OSSIFICATION; PSEUDARTHROSIS; REVIEW; RISK; SPINE FUSION; SPINE SURGERY; SURGEON;

ANIMALS; BONE SUBSTITUTES; BONE TRANSPLANTATION; HUMANS; PSEUDARTHROSIS; SPINE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84864471090     PISSN: 03905616     EISSN: 18271855     Source Type: Journal    
DOI: None     Document Type: Review

References (130)

1. Wilson-Hench J. Osteoinduction. In: Williams DF, editor. Progress in biomedical engineering. Vol. 4. Definitions in biomaterials. Amsterdam: Elsevier; 1987. p. 29.
2. Albrektsson T, Johansson C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J 2001;10(Suppl 2):S96-101.
3. Albrektsson T, Branemark PI, Hansson HA, Lindstrom J. Osseointegrated titanium implants. Requirements for ensuring a longlasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 1981;52:155-70.
4. Branemark PI, Hansson BO, Adell R, Breine U, Lindstrom J, Hallen O, Ohman A. Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period. Scand J Plast Reconstr Surg Suppl 1977;16:1-132.
5. Subach BR, Haid RW, Rodts GE, Kaiser MG. Bone morphogenetic protein in spinal fusion: overview and clinical update. Neurosurg Focus 2001;10:E3.
6. Ilizarov GA. The tension-stress effect on the genesis and growth of tissues: Part II. The influence of the rate and frequency of distraction. Clin Orthop Relat Res 1989;239:263-85.
7. Burchardt H. The biology of bone graft repair. Clin Orthop Relat Res 1983;174:28-42.
8. Williams BJ, Smith JS, Fu KM, Hamilton DK, Polly DW Jr, Ames CP et al. Does bone morphogenetic protein increasethe incidence of perioperative complicationsin spinal fusion?: A comparison of 55862 cases of spinal fusion with and without bone morphogenetic protein. Spine 1976;36:1685-91.
9. Khan SN, Cammisa FP Jr, Sandhu HS, Diwan AD, Girardi FP, Lane JM. The biology of bone grafting. J Am Acad Orthop Surg 2005;13:77-86.
10. Gazdag AR, Lane JM, Glaser D, Forster RA. Alternatives to Autogenous Bone Graft: Efficacy and Indications. J Am Acad Orthop Surg 1995;3:1-8.
11. Chau AM, Mobbs RJ. Bone graft substitutes in anterior cervical discectomy and fusion. Eur Spine J 2009;18:449-64.
12. Vaccaro AR, Chiba K, Heller JG, Patel T, Thalgott JS, Truumees E et al. Bone grafting alternatives in spinal surgery. Spine J 2002;2:206-15.
13. Anderson DG, Albert TJ. Bone grafting, implants, and plating options for anterior cervical fusions. Orthop Clin North Am 2002;33:317-28.
14. Boden SD SJ. Fusion. Biology of lumbar spine fusion and bone graft materials. In: International Society for Study of the Lumbar Spine Editorial Commitee, editors The lumbar spine. 2nd ed. Philadelphia, PA: WB Saunders; 1996. p. 1284-306.
15. Enneking WF, Burchardt H, Puhl JJ, Piotrowski G. Physical and biological aspects of repair in dog cortical-bone transplants. J Bone Joint Surg Am 1975;57:237-52.
16. Blumenthal S, McAfee PC, Guyer RD, Hochschuler SH, Geisler FH, Holt RT et al. A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes. Spine 2005;30:1565-75; discussion E1387-1591.
17. Enneking WF, Eady JL, Burchardt H. Autogenous cortical bone grafts in the reconstruction of segmental skeletal defects. J Bone Joint Surg Am 1980;62:1039-58.
18. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 1996;329:300-9.
19. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 1995;20:1055-60.
20. Younger EM, Chapman MW: Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-5.
21. Rawlinson JN. Morbidity after anterior cervical decompression and fusion. The influence of the donor site on recovery, and the results of a trial of surgibone compared to autologous bone. Acta Neurochir (Wien) 1994;131:106-18.
22. Schnee CL, Freese A, Weil RJ, Marcotte PJ. Analysis of harvest morbidity and radiographic outcome using autograft for anterior cervical fusion. Spine 1997;22:2222-7.
23. Silber JS, Anderson DG, Daffner SD, Brislin BT, Leland JM, Hili brand AS et al. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 2003;28:134-9.
24. Barlocher CB, Barth A, Krauss JK, Binggeli R, Seiler RW. Comparative evaluation of microdiscectomy only, autograft fusion, polymethylmethacrylate interposition, and threaded titanium cage fusion for treatment of single-level cervical disc disease: a prospective randomized study in 125 patients. Neurosurg Focus 2002;12:E4.
25. Rosenorn J, Hansen EB, Rosenorn MA. Anterior cervical discectomy with and without fusion. A prospective study. J Neurosurg 1983;59:252-5.
26. van den Bent MJ, Oosting J, Wouda EJ, van Acker RE, Ansink BJ, Braakman R. Anterior cervical discectomy with or without fusion with acrylate. A randomized trial. Spine 1996;21:834-9; discussion 840.
27. Frost HM. The biology of fracture healing. An overview for clinicians. Part I. Clin Orthop Relat Res 1989;248:283-93.
28. Frost HM. The biology of fracture healing. An overview for clinicians. Part II. Clin Orthop Relat Res 1989;248:294-309.
29. Burwell RG. The function of bone marrow in the incorporation of a bone graft. Clin Orthop Relat Res 1985;200:125-41.
30. Connolly JF, Guse R, Tiedeman J, Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 1991;266:259-70.
31. Bos GD, Goldberg VM, Powell AE, Heiple KG, Zika JM. The effect of histocompatibility matching on canine frozen bone allografts. J Bone Joint Surg Am 1983;65:89-96.
32. Wigfield CC, Nelson RJ. Nonautologous interbody fusion materials in cervical spine surgery: how strong is the evidence to justify their use? Spine 2001;26:687-94.
33. Jorgenson SS, Lowe TG, France J, Sabin J. A prospective analysis of autograft versus allograft in posterolateral lumbar fusion in the same patient. A minimum of 1-year follow-up in 144 patients. Spine 1994;19:2048-53.
34. Buck BE, Malinin TI, Brown MD. Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop Relat Res 1989;240:129-36.
35. McCarthy RE, Peek RD, Morrissy RT, Hough AJ Jr. Allograft bone in spinal fusion for paralytic scoliosis. J Bone Joint Surg Am 1986;68:370-5.
36. Collis JS. Total disc replacement: a modified posterior lumbar interbody fusion. Report of 750 cases. Clin Orthop Relat Res 1985;193:64-7.
37. Dodd CA, Fergusson CM, Freedman L, Houghton GR, Thomas D. Allograft versus autograft bone in scoliosis surgery. J Bone Joint Surg Br 1988;70:431-4.
38. Knapp DR Jr, Jones ET. Use of cortical cancellous allograft for posterior spinal fusion. Clin Orthop Relat Res 1988;229:99-106.
39. Bridwell KH, O'Brien MF, Lenke LG, Baldus C, Blanke K. Posterior spinal fusion supplemented with only allograft bone in paralytic scoliosis. Does it work? Spine 1994;19:2658-66.
40. Liljenqvist U, O'Brien JP, Renton P. Simultaneous combined anterior and posterior lumbar fusion with femoral cortical allograft. Eur Spine J 1998;7:125-31.
41. Zigler J, Delamarter R, Spivak JM, Linovitz RJ, Danielson GO 3rd, Haider TT et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-1162; discussion 1163.
42. Sim FH, Frassica FJ. Use of allografts following resection of tumors of the musculoskeletal system. Instr Course Lect 1993;42:405-13.
43. Weiss LE, Vaccaro AR, Scuderi G, McGuire M, Garfin SR. Pseudarthrosis after postoperative wound infection in the lumbar spine. J Spinal Disord 1997;10:482-7.
44. Wimmer C, Krismer M, Gluch H, Ogon M, Stockl B. Autogenic versus allogenic bone grafts in anterior lumbar interbody fusion. Clin Orthop Relat Res 1999;360:122-6.
45. Ehrler DM, Vaccaro AR. The use of allograft bone in lumbar spine surgery. Clin Orthop Relat Res 2000;371:38-45.
46. Barriga A, Diaz-de-Rada P, Barroso JL, Alfonso M, Lamata M, Hernaez S et al. Frozen cancellous bone allografts: positive cultures of implanted grafts in posterior fusions of the spine. Eur Spine J 2004;13:152-6.
47. Brantigan JW. Pseudarthrosis rate after allograft posterior lumbar interbody fusion with pedicle screw and plate fixation. Spine 1994;19:1271-9; discussion 1280.
48. Yue WM, Brodner W, Highland TR. Long-term results after anterior cervical discectomy and fusion with allograft and plating: a 5- to 11-year radiologic and clinical follow-up study. Spine 2005;30:2138-44.
49. Miller LE, Block JE. Safety and effectiveness of bone allografts in anterior cervical discectomy and fusion surgery. Spine 2011;36:2045-50.
50. Zhang X, Chen C, Zhang Y, Wang Z, Wang B, Yan W, Li M et al. Randomized, Controlled, Multicenter, Clinical Trial Comparing BRYAN Cervical Disc Arthroplasty with Anterior Cervical Decompression and Fusion in China. Spine 2011[Epub ahead of print].
51. Murrey D, Janssen M, Delamarter R, Goldstein J, Zigler J, Tay B et al. Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease. Spine J 2009;9:275-86.
52. Cutler AR, Siddiqui S, Mohan AL, Hillard VH, Cerabona F, Das K. Comparison of polyetheretherketone cages with femoral cortical bone allograft as a single-piece interbody spacer in transforaminal lumbar interbody fusion. J Neurosurg Spine 2006;5:534-9.
53. Pavlov PW, Meijers H, van Limbeek J, Jacobs WC, Lemmens JA, Obradov-Rajic M et al. Good outcome and restoration of lordosis after anterior lumbar interbody fusion with additional posterior fixation. Spine 2004;29:1893-9; discussion 1900.
54. Payer M. Implantation of a distractible titanium cage after cervical corpectomy: technical experience in 20 consecutive cases. Acta Neurochir (Wien) 2006;148:1173-0; discussion 1180.
55. Bruneau M, Nisolle JF, Gilliard C, Gustin T. Anterior cervical interbody fusion with hydroxyapatite graft and plate system. Neurosurg Focus 2001;10:E8.
56. Ryu SI, Mitchell M, Kim DH. A prospective randomized study comparing a cervical carbon fiber cage to the Smith-Robinson technique with allograft and plating: up to 24 months followup. Eur Spine J 2006;15:157-64.
57. Frederic S, Benedict R, Payer M. Implantation of an empty carbon fiber cage or a tricortical iliac crest autograft after cervical discectomy for single-level disc herniation: a prospective comparative study. J Neurosurg Spine 2006;4:292-9.
58. Brantigan JW, Steffee AD. A carbon fiber implant to aid inter-body lumbar fusion. Two-year clinical results in the first 26 patients. Spine 1993;18:2106-7.
59. Abbushi A, Cabraja M, Thomale UW, Woiciechowsky C, Kroppenstedt SN. The influence of cage positioning and cage type on cage migration and fusion rates in patients with monosegmental posterior lumbar interbody fusion and posterior fixation. Eur Spine J 2009;18:1621-8.
60. McKenna PJ, Freeman BJ, Mulholland RC, Grevitt MP, Webb JK, Mehdian SH. A prospective, randomised controlled trial of femoral ring allograft versus a titanium cage in circumferential lumbar spinal fusion with minimum 2-year clinical results. Eur Spine J 2005;14:727-37.
61. Cabraja M, Abbushi A, Kroppenstedt S, Woiciechowsky C. Cages with fixation wings versus cages plus plating for cervical reconstruction after corpectomy - is there any difference? Cen Eur Neurosurg 2011;71:59-63.
62. Cabraja M, Abbushi A, Koeppen D, Kroppenstedt S, Woiciechowsky C. Comparison between anterior and posterior decompression with instrumentation for cervical spondylotic myelopathy: sagittal alignment and clinical outcome. Neurosurg Focus 2011;28:E15.
63. Son SH, Kang YN, Ryu MR. The effect of metallic implants on radiation therapy in spinal tumor patients with metallic spinal implants. Med Dosim 2011 [Epub ahead of print].
64. Johansson CB, Roser K, Bolind P, Donath K, Albrektsson T. Bone-tissue formation and integration of titanium implants: an evaluation with newly developed enzyme and immunohisto-chemical techniques. Clin Implant Dent Relat Res 1999;1:33-40.
65. Verran J, Whitehead K. Factors affecting microbial adhesion to stainless steel and other materials used in medical devices. Int J Artif Organs 2005;28:1138-45.
66. Brantigan JW, Steffee AD, Lewis ML, Quinn LM, Persenaire JM. Lumbar interbody fusion using the Brantigan I/F cage for posterior lumbar interbody fusion and the variable pedicle screw placement system: two-year results from a Food and Drug Administration investigational device exemption clinical trial. Spine 2000;25:1437-46.
67. Diedrich O, Perlick L, Schmitt O, Kraft CN. Radiographic characteristics on conventional radiographs after posterior lumbar interbody fusion: comparative study between radiotranslucent and radiopaque cages. J Spinal Disord 2001;14:522-32.
68. Disch AC, Schaser KD, Melcher I, Feraboli F, Schmoelz W, Druschel C, Luzzati A. Oncosurgical results of multilevel thoracolumbar en-bloc spondylectomy and reconstruction with a carbon composite vertebral body replacement system. Spine 2011;36:E647-55.
69. Lemcke J, Al-Zain F, Meier U, Suess O. Polyetheretherketone (PEEK) Spacers for Anterior Cervical Fusion: A Retrospective Comparative Effectiveness Clinical Trial. Open Orthop J 2011;5:348-53.
70. Teo EC, Yang K, Fuss FK, Lee KK, Qiu TX, Ng HW. Effects of cervical cages on load distribution of cancellous core: a finite element analysis. J Spinal Disord Tech 2004;17:226-31.
71. Fernandez-Fairen M, Sala P, Dufoo M Jr, Ballester J, Murcia A, Merzthal L. Anterior cervical fusion with tantalum implant: a prospective randomized controlled study. Spine 2008;33465-72.
72. Wang JC, Yu WD, Sandhu HS, Tarn V, Delamarter RB. A comparison of magnetic resonance and computed tomographic image quality after the implantation of tantalum and titanium spinal instrumentation. Spine 1998;23:1684-8.
73. Grote W, Rottgen P. [The ventral fusion in cervical osteochondrosis and its treatment results]. Acta Neurochir 1967;16:218-40.
74. Schroder J, Grosse-Dresselhaus F, Schul C, Wassmann H. PMMA versus titanium cage after anterior cervical discectomy - a prospective randomized trial. Zentralbl Neurochir 2007;68:2-7.
75. Schroder J, Wassmann H. [Polymethylmethacrylate (PMMA) in anterior cervical spine surgery - current situation in Germany]. Zentralbl Neurochir 2001;62:33-6.
76. Hamburger C, Festenberg FV, Uhl E. Ventral discectomy with pmma interbody fusion for cervical disc disease: long-term results in 249 patients. Spine 2001;26:249-55.
77. Vieweg U. [Possibilities for cost reduction of implants in spinal surgery]. Zentralbl Neurochir 2003;64:159-65.
78. Jollenbeck B, Fernandez N, Firsching R. Titanium or polymethylmethacrylate in cervical disc surgery? A prospective study. Zentralbl Neurochir 2001;62:200-2.
79. Cabraja M, Koeppen D, Lanksch WR, Maier-Hauff K, Kroppenstedt S. Polymethylmethacrylate-assisted ventral discectomy: rate of pseudarthrosis and clinical outcome with a minimum followup of 5 years. BMC Musculoskelet Disord 2011;12:140.
80. Daculsi G, LeGeros RZ, Nery E, Lynch K, Kerebel B. Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. J Biomed Mater Res 1989;23:883-94.
81. Zhou H, Lee J. Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomater 2011;7:2769-81.
82. Muschik M, Ludwig R, Halbhubner S, Bursche K, Stoll T. Betatricalcium phosphate as a bone substitute for dorsal spinal fusion in adolescent idiopathic scoliosis: preliminary results of a prospective clinical study. Eur Spine J 2001;10(Suppl 2):S178-84.
83. Ransford AO, Morley T, Edgar MA, Webb P, Passuti N, Chopin D et al. Synthetic porous ceramic compared with autograft in scoliosis surgery. A prospective, randomized study of 341 patients. J Bone Joint Surg Br 1998;80:13-8.
84. Baas J, Svaneby D, Jensen TB, Elmengaard B, Bechtold J, Soballe K. Coralline hydroxyapatite granules inferior to morselized allograft around uncemented porous Ti implants: unchanged fixation by addition of concentrated autologous bone marrow aspirate. J Biomed Mater Res A 2011;99:9-15.
85. van Haaren EH, Smit TH, Phipps K, Wuisman PI, Blunn G, Heyligers IC. Tricalcium-phosphate and hydroxyapatite bone-graft extender for use in impaction grafting revision surgery. An in vitro study on human femora. J Bone Joint Surg Br 2005;87:267-71.
86. Jensen TB, Overgaard S, Lind M, Rahbek O, Bunger C, Soballe K. Osteogenic protein-1 increases the fixation of implants grafted with morcellised bone allograft and ProOsteon bone substitute: an experimental study in dogs. J Bone Joint Surg Br 2007;89:121-6.
87. Nauth A, Ristevski B, Li R, Schemitsch EH. Growth factors and bone regeneration: how much bone can we expect? Injury 2011;42:574-9.
88. Sys J, Weyler J, Van Der Zijden T, Parizel P, Michielsen J. Plateletrich plasma in mono-segmental posterior lumbar interbody fusion. Eur Spine J 2011;20:1650-7.
89. rd et al. Augment(R) Bone Graft Products Compare Favorably to Autologous Bone Graft in an Ovine Model of Lumbar Interbody Spine Fusion. Spine 2011 [Epub ahead of print]
90. Salo J, Kaigle Holm A, Indahl A, Mackiewicz Z, Sukura A, Holm S et al. Expression of vascular endothelial growth factor receptors coincide with blood vessel in-growth and reactive bone remodelling in experimental intervertebral disc degeneration. Clin Exp Rheumatol 2008;26:1018-26.
91. Urist MR. Bone: formation by autoinduction. Science 1965;150:893-9.
92. Itoh H, Ebara S, Kamimura M, Tateiwa Y, Kinoshita T, Yuzawa Y, Takaoka K. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 1999;24:1402-5.
93. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 1990;87:9843-7.
94. Nakase T, Nomura S, Yoshikawa H, Hashimoto J, Hirota S, Kitamura Y et al. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 1994;9:651-9.
95. Ishidou Y, Kitajima I, Obama H, Maruyama I, Murata F, Imamura T et al. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res 1995;10:1651-9.
96. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M et al. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 1998;22:605-12.
97. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M et al. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 1996;335:555-61.
98. Kawaguchi H, Kurokawa T, Hoshino Y, Kawahara H, Ogata E, Matsumoto T. Immunohistochemical demonstration of bone morphogenetic protein-2 and transforming growth factor-beta in the ossification of the posterior longitudinal ligament of the cervical spine. Spine 1992;17(3 Suppl):S33-6.
99. Kon T, Yamazaki M, Tagawa M, Goto S, Terakado A, Moriya H et al. Bone morphogenetic protein-2 stimulates differentiation of cultured spinal ligament cells from patients with ossification of the posterior longitudinal ligament. Calcif Tissue Int 1997;60:291-6.
100. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 1990;87:2220-4.
101. Boden SD, Schimandle JH, Hutton WC. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species. Spine 1995;20:2633-44.
102. Aspenberg P, Turek T. BMP-2 for intramuscular bone induction: effect in squirrel monkeys is dependent on implantation site. Acta Orthop Scand 1996;67:3-6.
103. Boden SD, Martin GJ Jr, Horton WC, Truss TL, Sandhu HS. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 1998;11:95-101.
104. Sandhu HS, Kanim LE, Toth JM, Kabo JM, Liu D, Delamarter RB et al. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine 1997; 22:1171-80.
105. Vaccaro AR, Patel T, Fischgrund J, Anderson DG, Truumees E, Herkowitz H et al. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 2003;12:495-500.
106. Vaccaro AR, Patel T, Fischgrund J, Anderson DG, Truumees E, Herkowitz H et al. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 2005;14:623-9.
107. Blatten TR, Delling G, Dalai PS, Toth CA, Balling H, Weckbach A. Successful transpedicular lumbar interbody fusion by means of a composite of osteogenic protein-1 (rhBMP-7) and hydroxyapatite carrier: a comparison with autograft and hydroxyapatite in the sheep spine. Spine 2002;27:2697-705.
108. McKay B, Sandhu HS. Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine 2002;27(16 Suppl 1):S66-85.
109. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20:1326-37.
110. Baskin DS, Ryan P, Sonntag V, Westmark R, Widmayer MA. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine 2003;28:1219-24; discussion 1225.
111. Boakye M, Mummaneni PV, Garrett M, Rodts G, Haid R. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine 2005;2:521-5.
112. Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 2002;27:2662-73.
113. Burkus JK. Bone morphogenetic proteins in anterior lumbar interbody fusion: old techniques and new technologies. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 2004;1:254-60.
114. Poynton AR, Lane JM. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 2002;27(16 Suppl 1):S40-8.
115. Alexander JT, Branch CLJr, Subach BR, Haid RWJr. Applications of a resorbable interbody spacer via a posterior lumbar interbody fusion technique. Orthopedics 2002;25(10 Suppl):s1185-9; discussion s1189.
116. Alexander JT, Branch CL Jr, Subach BR, Haid RW Jr. Applications of a resorbable interbody spacer in posterior lumbar interbody fusion. J Neurosurg 2002;97(4 Suppl):468-72.
117. Haid RW Jr, Branch CL Jr, Alexander JT, Burkus JK. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 2004;4:527-38.
118. Mummaneni PV, Pan J, Haid RW, Rodts GE. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 2004;1:19-23.
119. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002;15:337-49.
120. Boden SD, Zdeblick TA, Sandhu HS, Heim SE. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteo-induction in humans: a preliminary report. Spine 2000;25:376-81.
121. Lad SP, Nathan JK, Boakye M. Trends in the use of bone morphogenetic protein as a substitute to autologous iliac crest bone grafting for spinal fusion procedures in the United States. Spine 2011;36:E274-81.
122. Burkus JK, Transfeldt EE, Kitchel SH, Watkins RG, Balderston RA. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 2002;27:2396-408.
123. Vaidya R, Carp J, Sethi A, Bartol S, Craig J, Les CM. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 2007;16:1257-65.
124. Cahill KS, Chi JH, Day A, Claus EB. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 2009;302:58-66.
125. Shen HX, Buchowski JM, Yeom JS, Liu G, Lin N, Riew KD. Pseudarthrosis in multilevel anterior cervical fusion with rhBMP-2 and allograft: analysis of one hundred twenty-seven cases with minimum two-year follow-up. Spine 2011;35:747-53.
126. Lee KB, Taghavi CE, Hsu MS, Song KJ, Yoo JH, Keorochana G et al. The efficacy of rhBMP-2 versus autograft for posterolateral lumbar spine fusion in elderly patients. Eur Spine J 2011;19:924-30.
127. Smoljanovic T, Rakovac M, Bojanic I. Could chronic host inflammatory response be responsible for delayed onset of retrograde ejaculation after the labeled use of recombinant human bone morphogenetic protein-2? Spine J 2011;11:167-8.
128. Carragee EJ, Mitsunaga KA, Hurwitz EL, Scuderi GJ. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study. Spine J 2011;11:511-6.
129. Smoljanovic T, Siric F, Bojanic I. Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2. J Bone Joint Surg Am 2011;92:2614-5; author reply 2615-6.
130. Carragee EJ, Ghanayem AJ, Weiner BK, Rothman DJ, Bono CM. A challenge to ntegrity in spine publications: years of living dangerously with the promotion of bone growth factors. Spine J 2011;11:463-8.